The global Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ 20600 million in 2023 and is anticipated to reach US$ 29690 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.

Non-Steroidal Anti-Inflammatory Drugs Market

Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs.

Report Scope

The Non-Steroidal Anti-Inflammatory Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Steroidal Anti-Inflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Steroidal Anti-Inflammatory Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Steroidal Anti-Inflammatory Drugs Market Report

Report Metric	Details
Report Name	Non-Steroidal Anti-Inflammatory Drugs Market
Accounted market size in 2023	US$ 20600 million
Forecasted market size in 2030	US$ 29690 million
CAGR	5.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Non-Selective NSAIDs COX-2 Selective NSAIDs
Segment by Application	Dental Pain Muscle Aches Pain caused by Gout Bursitis Menstrual Cramps Fever Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc., Merck & Co., Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Steroidal Anti-Inflammatory Drugs Market growing?

Ans: The Non-Steroidal Anti-Inflammatory Drugs Market witnessing a CAGR of 5.4% during the forecast period 2024-2030.

What is the Non-Steroidal Anti-Inflammatory Drugs Market size in 2030?

Ans: The Non-Steroidal Anti-Inflammatory Drugs Market size in 2030 will be US$ 29690 million.

Who are the main players in the Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The main players in the Non-Steroidal Anti-Inflammatory Drugs Market are Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc., Merck & Co., Inc.

What are the Application segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The Applications covered in the Non-Steroidal Anti-Inflammatory Drugs Market report are Dental Pain, Muscle Aches, Pain caused by Gout, Bursitis, Menstrual Cramps, Fever, Others

What are the Type segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The Types covered in the Non-Steroidal Anti-Inflammatory Drugs Market report are Non-Selective NSAIDs, COX-2 Selective NSAIDs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Non-Selective NSAIDs

1.2.3 COX-2 Selective NSAIDs

1.3 Market by Application

1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Dental Pain

1.3.3 Muscle Aches

1.3.4 Pain caused by Gout

1.3.5 Bursitis

1.3.6 Menstrual Cramps

1.3.7 Fever

1.3.8 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Perspective (2019-2030)

2.2 Non-Steroidal Anti-Inflammatory Drugs Growth Trends by Region

2.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Region (2019-2024)

2.2.3 Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Region (2025-2030)

2.3 Non-Steroidal Anti-Inflammatory Drugs Market Dynamics

2.3.1 Non-Steroidal Anti-Inflammatory Drugs Industry Trends

2.3.2 Non-Steroidal Anti-Inflammatory Drugs Market Drivers

2.3.3 Non-Steroidal Anti-Inflammatory Drugs Market Challenges

2.3.4 Non-Steroidal Anti-Inflammatory Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Revenue

3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Revenue (2019-2024)

3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs Revenue

3.4 Global Non-Steroidal Anti-Inflammatory Drugs Market Concentration Ratio

3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2023

3.5 Non-Steroidal Anti-Inflammatory Drugs Key Players Head office and Area Served

3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs Product Solution and Service

3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Steroidal Anti-Inflammatory Drugs Breakdown Data by Type

4.1 Global Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Type (2019-2024)

4.2 Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Type (2025-2030)

5 Non-Steroidal Anti-Inflammatory Drugs Breakdown Data by Application

5.1 Global Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Application (2019-2024)

5.2 Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030)

6.2 North America Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024)

6.4 North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030)

7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024)

7.4 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030)

8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030)

9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024)

9.4 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size (2019-2030)

10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer Inc.

11.1.1 Pfizer Inc. Company Detail

11.1.2 Pfizer Inc. Business Overview

11.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction

11.1.4 Pfizer Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.1.5 Pfizer Inc. Recent Development

11.2 Bayer AG

11.2.1 Bayer AG Company Detail

11.2.2 Bayer AG Business Overview

11.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Introduction

11.2.4 Bayer AG Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.2.5 Bayer AG Recent Development

11.3 GSK plc

11.3.1 GSK plc Company Detail

11.3.2 GSK plc Business Overview

11.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Introduction

11.3.4 GSK plc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.3.5 GSK plc Recent Development

11.4 Dr. Reddy’s Laboratories Ltd

11.4.1 Dr. Reddy’s Laboratories Ltd Company Detail

11.4.2 Dr. Reddy’s Laboratories Ltd Business Overview

11.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Introduction

11.4.4 Dr. Reddy’s Laboratories Ltd Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.4.5 Dr. Reddy’s Laboratories Ltd Recent Development

11.5 Viatris Inc

11.5.1 Viatris Inc Company Detail

11.5.2 Viatris Inc Business Overview

11.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Introduction

11.5.4 Viatris Inc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.5.5 Viatris Inc Recent Development

11.6 Teva Pharmaceutical Industries Ltd.

11.6.1 Teva Pharmaceutical Industries Ltd. Company Detail

11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Introduction

11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.7 Johnson And Johnson Services, Inc.

11.7.1 Johnson And Johnson Services, Inc. Company Detail

11.7.2 Johnson And Johnson Services, Inc. Business Overview

11.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction

11.7.4 Johnson And Johnson Services, Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.7.5 Johnson And Johnson Services, Inc. Recent Development

11.8 Merck & Co., Inc.

11.8.1 Merck & Co., Inc. Company Detail

11.8.2 Merck & Co., Inc. Business Overview

11.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction

11.8.4 Merck & Co., Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

11.8.5 Merck & Co., Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Bayer

GSK

Dr. Reddy’s Laboratories Ltd.

Viatris

Teva Pharmaceutical Industries Ltd

Johnson and Johnson Services Inc.

Merck& Co. Inc

List of Tables

Table 1. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Non-Selective NSAIDs

Table 3. Key Players of COX-2 Selective NSAIDs

Table 4. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2019-2024)

Table 8. Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2025-2030)

Table 10. Non-Steroidal Anti-Inflammatory Drugs Market Trends

Table 11. Non-Steroidal Anti-Inflammatory Drugs Market Drivers

Table 12. Non-Steroidal Anti-Inflammatory Drugs Market Challenges

Table 13. Non-Steroidal Anti-Inflammatory Drugs Market Restraints

Table 14. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Players (2019-2024)

Table 16. Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2023)

Table 17. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Non-Steroidal Anti-Inflammatory Drugs Product Solution and Service

Table 21. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2019-2024)

Table 29. Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2025-2030)

Table 31. North America Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Pfizer Inc. Company Detail

Table 47. Pfizer Inc. Business Overview

Table 48. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product

Table 49. Pfizer Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 50. Pfizer Inc. Recent Development

Table 51. Bayer AG Company Detail

Table 52. Bayer AG Business Overview

Table 53. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product

Table 54. Bayer AG Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 55. Bayer AG Recent Development

Table 56. GSK plc Company Detail

Table 57. GSK plc Business Overview

Table 58. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product

Table 59. GSK plc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 60. GSK plc Recent Development

Table 61. Dr. Reddy’s Laboratories Ltd Company Detail

Table 62. Dr. Reddy’s Laboratories Ltd Business Overview

Table 63. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product

Table 64. Dr. Reddy’s Laboratories Ltd Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 65. Dr. Reddy’s Laboratories Ltd Recent Development

Table 66. Viatris Inc Company Detail

Table 67. Viatris Inc Business Overview

Table 68. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product

Table 69. Viatris Inc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 70. Viatris Inc Recent Development

Table 71. Teva Pharmaceutical Industries Ltd. Company Detail

Table 72. Teva Pharmaceutical Industries Ltd. Business Overview

Table 73. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product

Table 74. Teva Pharmaceutical Industries Ltd. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 75. Teva Pharmaceutical Industries Ltd. Recent Development

Table 76. Johnson And Johnson Services, Inc. Company Detail

Table 77. Johnson And Johnson Services, Inc. Business Overview

Table 78. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product

Table 79. Johnson And Johnson Services, Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 80. Johnson And Johnson Services, Inc. Recent Development

Table 81. Merck & Co., Inc. Company Detail

Table 82. Merck & Co., Inc. Business Overview

Table 83. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product

Table 84. Merck & Co., Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024) & (US$ Million)

Table 85. Merck & Co., Inc. Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Type: 2023 VS 2030

Figure 3. Non-Selective NSAIDs Features

Figure 4. COX-2 Selective NSAIDs Features

Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Application: 2023 VS 2030

Figure 7. Dental Pain Case Studies

Figure 8. Muscle Aches Case Studies

Figure 9. Pain caused by Gout Case Studies

Figure 10. Bursitis Case Studies

Figure 11. Menstrual Cramps Case Studies

Figure 12. Fever Case Studies

Figure 13. Others Case Studies

Figure 14. Non-Steroidal Anti-Inflammatory Drugs Report Years Considered

Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region: 2023 VS 2030

Figure 18. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Players in 2023

Figure 19. Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2023

Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2019-2030)

Figure 23. United States Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2019-2030)

Figure 27. Germany Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2019-2030)

Figure 35. China Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2019-2030)

Figure 43. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2019-2030)

Figure 47. Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Pfizer Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 50. Bayer AG Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 51. GSK plc Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 52. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 53. Viatris Inc Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 55. Johnson And Johnson Services, Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 56. Merck & Co., Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions